Ratnagene Lifescience Private Limited, a amalgamated private limited company, was established on 15 September 2021 in Ahmadabad City, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231GJ2021PTC125613. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹9.00 Cr and a paid-up capital of ₹6.86 Cr.
It upholds a compliant status. Employing 45 professional, Its leadership includes Swapnil Jatinbhai Shah (Director), Chetan Bipinchandra Shah (Director), Rishabh Mahendrakumar Sanghvi (Director). Past directors included Chetan Bipinchandra Shah, Deval Rajnikant Shah, Vinay Khandelwal. It holds ₹77.25 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 1004-1006, 10Th Floor, North Tower,, Off. Ambli Road, Opp. Ashok Vatika,, Ahmadabad City, Gujarat, 380054.
U24231GJ2021PTC125613
125613
15 September 2021
₹9.00 Cr
₹6.86 Cr
Roc Ahmedabad
Unlisted
Amalgamated
Explore comprehensive insights into Ratnagene Lifescience Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Swapnil Jatinbhai Shah | Director | 15 Sep 2021 | Current |
| Chetan Bipinchandra Shah | Director | 05 Feb 2024 | Current |
| Rishabh Mahendrakumar Sanghvi | Director | 15 Sep 2021 | Current |
| Deval Rajnikant Shah | Director | 05 Feb 2024 | Current |
| Vinay Khandelwal | Director | 01 Sep 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 08 Feb 2024 | Past |
| Pramod Abcsdd | Additional Director | 08 Feb 2024 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ratnagene Lifescience Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth moved up by a moderate rise of 9.21%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
In 2023, Ratnagene Lifescience had a promoter holding of 87.46% and a public holding of 12.54%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹772,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jun 2023 | Hdfc Bank Limited | ₹40.00 Cr | Open |
| 03 Apr 2023 | Hdfc Bank Limited | ₹37.25 Cr | Open |
Explore comprehensive loan charge details -
Ratnagene Lifescience has a workforce of 45 employees as of Jan 03, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ratnagene Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ratnagene Lifescience's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Chetan Bipinchandra Shah was appointed as a Director was appointed as a Director on 05 Feb 2024 & has been associated with this company since 1 year 10 months . was completed.
Deval Rajnikant Shah was appointed as a Director was appointed as a Director on 05 Feb 2024 & has been associated with this company since 1 year 10 months . was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited of Rs. 37.25 Cr registered on 03 Apr 2023 with Charge ID 100706667 was modified on 12 Jan 2024. was documented.
Progress on Ratnagene Lifescience Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 40.00 Cr with Charge ID 100762760 was registered on 23 Jun 2023. was documented.
A charge with Hdfc Bank Limited amounted to Rs. 37.25 Cr with Charge ID 100706667 was registered on 03 Apr 2023. was recorded as a recent event.
The CIN of Ratnagene Lifescience Private Limited is U24231GJ2021PTC125613.
Ratnagene Lifescience Private Limited is headquartered at 1004-1006, 10Th Floor, North Tower,, Off. Ambli Road, Opp. Ashok Vatika,, Ahmadabad City, Gujarat, 380054.
Ratnagene Lifescience Private Limited was incorporated on 15 September 2021.
The current directors of Ratnagene Lifescience Private Limited are
The primary industry of Ratnagene Lifescience Private Limited is Manufacturing.
Ratnagene Lifescience Private Limited is unlisted.
The authorized capital of Ratnagene Lifescience Private Limited is ₹9.00 Cr, and the paid-up capital is ₹6.86 Cr.
The compliance status of Ratnagene Lifescience Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX